FIELD: medicine. SUBSTANCE: method involves additionally determining antibodies to M. Leprae of IgG and IgM class by means of M. Lufu antigens in the cases of antibodies to M. Leprae of IgA class being found in immunoenzyme assay. Antibodies level being found to be equal to or greater than 0.40, leprosis is to be diagnosed. EFFECT: enhanced accuracy in diagnosing leprosy cases. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF LEPROSY DIAGNOSIS | 1996 |
|
RU2124730C1 |
| METHOD OF ESTIMATION OF LEPROSY RELAPSE RISK GROUP | 1993 |
|
RU2082979C1 |
| METHOD OF IDENTIFICATION OF MYCOBACTERIUM LEPRAE IN PATIENTS WITH DISEASE REGRESSION | 1997 |
|
RU2137137C1 |
| METHOD FOR Mycobacterium leprae ANTIBODY TEST | 2012 |
|
RU2501022C2 |
| METHOD OF IMMUNOPROPHYLAXIS OF EXPERIMENTAL LEPROSY INFECTION | 1996 |
|
RU2135196C1 |
| METHOD FOR Mycobacterium leprae ANTIBODY TEST | 2012 |
|
RU2500423C1 |
| METHOD OF DIAGNOSIS OF LEPROUS PROCESS ACTIVITY | 2000 |
|
RU2170431C1 |
| METHOD FOR DETERMINING LEPROSY FORM | 2004 |
|
RU2279087C2 |
| STRAIN OF BACTERIUM MYCOBACTERIUM AVIUM USED FOR LEPROSY DIAGNOSIS | 1994 |
|
RU2080377C1 |
| METHOD OF DETECTION OF SPECIFIC LIVER DISEASE IN LEPROSY PATIENTS | 2009 |
|
RU2403869C1 |
